Lexaria Bioscience Corp. (LEXX) Financials
LEXX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| May 31, 2026 | 4.8 million | 437091 |
| Feb. 28, 2026 | 6.5 million | 276997 |
| Nov. 30, 2025 | 6.1 million | 1.5 million |
| Aug. 31, 2025 | 4.2 million | 1.6 million |
LEXX Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| May 31, 2026 | -1.6 million | 92944 |
| Feb. 28, 2026 | -2.2 million | 74895 |
| Nov. 30, 2025 | -989197 | 74895 |
| Aug. 31, 2025 | -2.7 million | 122724 |
LEXX Net Income
No data available :(
LEXX Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| May 31, 2026 | 3.6 million | - | 86714 |
| Feb. 28, 2026 | 5.3 million | - | 94386 |
| Nov. 30, 2025 | 4.4 million | - | 101920 |
| Aug. 31, 2025 | 2.0 million | - | 109320 |
LEXX Shares Outstanding
LEXX Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| May 31, 2026 | 61009 | 970834 | 1.0 million | - |
| Feb. 28, 2026 | 55910 | 475388 | 996515 | - |
| Nov. 30, 2025 | 5099 | 671340 | 902291 | - |
| Aug. 31, 2025 | 14611 | 1.9 million | 980477 | - |
LEXX Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| May 31, 2026 | - | - |
| Feb. 28, 2026 | 20000 | 26568 |
| Nov. 30, 2025 | - | 24197 |
| Aug. 31, 2025 | 174000 | 21398 |
LEXX Revenue by Segment
Graph available only for paid members. Upgrade to see it.
LEXX
Price: $0.40
52 week price:
Earnings Per Share: -0.34 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Canada
Volume: 7400
Market Capitalization: 15.8 million